TY - JOUR
T1 - Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium
AU - Acton, Thomas B.
AU - Gunsalus, Kristin C.
AU - Xiao, Rong
AU - Ma, Li Chung
AU - Aramini, James
AU - Baran, Michael C.
AU - Chiang, Yi Wen
AU - Climent, Teresa
AU - Cooper, Bonnie
AU - Denissova, Natalia G.
AU - Douglas, Shawn M.
AU - Everett, John K.
AU - Ho, Chi Kent
AU - Macapagal, Daphne
AU - Rajan, Paranji K.
AU - Shastry, Ritu
AU - Shih, Liang Yu
AU - Swapna, G. V T
AU - Wilson, Michael
AU - Wu, Margaret
AU - Gerstein, Mark
AU - Inouye, Masayori
AU - Hunt, John F.
AU - Montelione, Gaetano T.
N1 - Funding Information:
We thank Drs. S. Anderson, P. Manor, F. Piano, and A. Yee for helpful advice in developing this protein production platform. This work is supported by Grant P50-GM62413 from the Protein Structure Initiative of the National Institutes of Health, Institute of General Medical Sciences.
PY - 2005
Y1 - 2005
N2 - In this chapter we describe the core Protein Production Platform of the Northeast Structural Genomics Consortium (NESG) and outline the strategies used for producing high-quality protein samples using Escherichia coli host vectors. The platform is centered on 6X-His affinity-tagged protein constructs, allowing for a similar purification procedure for most targets, and the implementation of high-throughput parallel methods. In most cases, these affinity-purified proteins are sufficiently homogeneous that a single subsequent gel filtration chromatography step is adequate to produce protein preparations that are greater than 98% pure. Using this platform, over 1000 different proteins have been cloned, expressed, and purified in tens of milligram quantities over the last 36-month period (see Summary Statistics for All Targets, http://www.nmr.cabm. rutgers.edu/bioinformatics/ZebaView/). Our experience using a hierarchical multiplex expression and purification strategy, also described in this chapter, has allowed us to achieve success in producing not only protein samples but also many three-dimensional structures. As of December 2004, the NESG Consortium has deposited over 145 new protein structures to the Protein Data Bank (PDB); about two-thirds of these protein samples were produced by the NESG Protein Production Facility described here. The methods described here have proven effective in producing quality samples of both eukaryotic and prokaryotic proteins. These improved robotic and/or parallel cloning, expression, protein production, and biophysical screening technologies will be of broad value to the structural biology, functional proteomics, and structural genomics communities.
AB - In this chapter we describe the core Protein Production Platform of the Northeast Structural Genomics Consortium (NESG) and outline the strategies used for producing high-quality protein samples using Escherichia coli host vectors. The platform is centered on 6X-His affinity-tagged protein constructs, allowing for a similar purification procedure for most targets, and the implementation of high-throughput parallel methods. In most cases, these affinity-purified proteins are sufficiently homogeneous that a single subsequent gel filtration chromatography step is adequate to produce protein preparations that are greater than 98% pure. Using this platform, over 1000 different proteins have been cloned, expressed, and purified in tens of milligram quantities over the last 36-month period (see Summary Statistics for All Targets, http://www.nmr.cabm. rutgers.edu/bioinformatics/ZebaView/). Our experience using a hierarchical multiplex expression and purification strategy, also described in this chapter, has allowed us to achieve success in producing not only protein samples but also many three-dimensional structures. As of December 2004, the NESG Consortium has deposited over 145 new protein structures to the Protein Data Bank (PDB); about two-thirds of these protein samples were produced by the NESG Protein Production Facility described here. The methods described here have proven effective in producing quality samples of both eukaryotic and prokaryotic proteins. These improved robotic and/or parallel cloning, expression, protein production, and biophysical screening technologies will be of broad value to the structural biology, functional proteomics, and structural genomics communities.
UR - http://www.scopus.com/inward/record.url?scp=20144387833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20144387833&partnerID=8YFLogxK
U2 - 10.1016/S0076-6879(05)94008-1
DO - 10.1016/S0076-6879(05)94008-1
M3 - Article
C2 - 15808222
AN - SCOPUS:20144387833
SN - 0076-6879
VL - 394
SP - 210
EP - 243
JO - Methods in enzymology
JF - Methods in enzymology
ER -